Why Vivos Therapeutics Shares Are Soaring Today
Vivos Therapeutics (NASDAQ: VVOS) is surging higher today after the company announced the U.S. Food and Drug Administration granted 510(k) market clearance to its mmRNA device for treating mild to moderate OSA, sleep-disordered breathing and snoring in adults.
